The aim of this study was to assess the relationship between homocysteine (tHcy), folate and vitamin B 12 levels, urinary albumin excretion, and arterial blood pressure in patients with noninsulin-dependent diabetes mellitus (NIDDM). Our study was carried out in 33 NIDDM patients (16 men, 17 women) and 16 healthy volunteers as controls (seven men, nine women). Fasting and postmethionine load plasma tHcy levels were assessed, together with folate, vitamin B 12 , and urinary albumin excretion levels. In NIDDM patients, there were correlations between folate and mean arterial pressure (r ‫؍‬ ‫؍‬ ؊0.352, P ‫؍‬ ‫؍‬ .046), folate and systolic blood pressure (r ‫؍‬ ‫؍‬ ؊0.437, P ‫؍‬ ‫؍‬ .013), folate and vitamin B 12 (r ‫؍‬ ‫؍‬ 0.499, P ‫؍‬ ‫؍‬ .004), tHcy and vitamin B 12 (r ‫؍‬ ‫؍‬ ؊0.348, P ‫؍‬ ‫؍‬ .04), ln tHcy and ln folate (r ‫؍‬ ‫؍‬ ؊0.404, P ‫؍‬ ‫؍‬ .01), and, lastly, between tHcy, either fasting or postload, and urinary albumin excretion. Patients with elevated tHcy levels had significantly higher diastolic blood pressure (P ‫؍‬ ‫؍‬ .04) and mean arterial pressure (P ‫؍‬ ‫؍‬ .03). Otherwise, higher folate values were associated with lower systolic blood pressure (P ‫؍‬ ‫؍‬ .004) and mean arterial pressure (P ‫؍‬ ‫؍‬ .02). In addition, NIDDM patients with complications presented higher tHcy basal values than the group without complications (P ‫؍‬ ‫؍‬ .003). A particular propensity of such patients towards endothelial dysfunction could explain the presence of correlations between these metabolic parameters and arterial blood pressure. Am
F olate and vitamin B 12 are both involved in the determination of plasma homocysteine values. Homocysteine (tHcy) is an intermediate sulfhydryl amino acid formed during the conversion of methionine to cysteine. 1 Almost all of the population presented with tHcy plasma values ranging from 5 to 15 mol/L, but often, due to genetic or acquired factors, the plasma tHcy level was enhanced. [1] [2] [3] [4] This enhancement might be responsible for atherogenic and thrombotic tendencies. 1 Among the possible causes: an induction of cyclin A gene expression in vascular smooth muscle cells 5 ; an endothelial dysfunction 6 ; a reduced level of protein C, a natural anticoagulant involved in the blockage of factor V and VII of the coagulatory cascade 7 ; an inhibition of von Willebrand factor processing and secretion 8 ; an enhancement of lipid peroxidation 9 ; a direct endothelial damage caused by tHcy, due to a toxic sulphur-containing amino acid accumulation in endothelial cells 10 ;
an interaction between nitric oxide (NO) and tHcy 11, 12 ; and finally a reduction in serum antithrombin activity, with a reduction of thrombomodulin, which binds with thrombin. 13 A previous study has suggested that not only are plasma tHcy levels correlated with atherothrombotic events, but serum folate is also correlated with coronary artery disease.
14 Increased risks were not related only to individuals with extremely low serum folate levels, but were also observed for individuals with normal levels, suggesting that current definitions of appropriate serum folate levels might be reassessed. Furthermore, dietary folate was inversely associated with carotid artery stenosis in the Framingham Study.
14 None, previously, have demonstrated the presence of any relationship between arterial blood pressure and plasma folate or vitamin B 12 levels. Moreover, only a few studies have demonstrated an increase in plasma tHcy levels in hypertensive patients, whether asymptomatic 15, 16 or with cerebral infarction. 17 Particularly, we thought that non-insulin-dependent diabetes mellitus (NIDDM) patients might represent a special group of subjects, in which a propensity towards endothelial dysfunction could lead to an enhanced endothelial vulnerability. Slight variations in plasma homocysteine values, or differences in folate or vitamin B 12 levels, which are correlated with the methionine-homocysteine pathway, could induce alterations in arterial regulatory tone. Our purpose was to assess the role of homocysteine, folate, vitamin B 12 , and increased urinary albumin excretion (as a sign of systemic disorders of endothelial function 18 ) in influencing ambulatorial monitoring of arterial blood pressure in NIDDM patients.
PATIENTS AND METHODS
Our study was carried out in 33 NIDDM patients (16 men; 17 women; mean age, 60.9 Ϯ 5.93 years; duration of disease, 7.75 Ϯ 5.35 years), diagnosed as suggested in previous studies, 19 and 16 healthy volunteers as controls, (seven men, nine women), matched for age, gender, and Quatelet index. Patients and controls were enrolled from a diabetic center. During enrollment, we tried to maintain a 1:1:1 ratio between the groups of microalbuminuric:normoalbumunuric:control. All the patients and controls gave their informed consent to be enrolled in our study. They were normotensive without antihypertensive treatment, according to World Health Organization criteria. 20 If systolic blood pressure was greater than 160 mm Hg, or diastolic blood pressure greater than 95 mm Hg, patients were excluded from the study. If they had overt renal dysfunction (creatinine Ͼ 1.5 mg/dL) or hypercholesterolemia (plasma cholesterol Ͼ 240 mg/ dL), they were excluded from the study. Systemic blood pressure was determined at the arm after being in the supine position for at least 10 min, as the mean of at least three consecutive measurements by standard sphygmomanometry. Operators, during arterial blood pressure measurement, were blinded to patients' or controls' group, and, obviously, to plasma homocysteine levels.
Plasma homocysteine levels were assessed at baseline in both patients and controls, as was folate and vitamin B 12 . Furthermore, microalbuminuria, HbA 1c , creatinine, total cholesterol, HDL, triglycerides, number of leukocytes, smoking, the presence of complications, and therapy, were analyzed in NIDDM patients. Vitamin B 12 and folate levels were determined simultaneously in a single tube by the ICN Pharmaceuticals (Chicago, IL) SimulTRACSNB Radioassay Kit. All patients and controls were subjected to the methionine load test, because in some patients with impaired homocysteine metabolism, fasting concentrations may be normal. 21 Participants were phlebotomized after an overnight fast (10 to 14 h), and blood samples were taken at baseline and once again 5 h after receiving an oral load (0.1 g/kg body weight) of l-methionine.
21
All whole blood specimens for homocysteine analysis were drawn into vacutainers containing EDTA, and immediately refrigerated at 4°C. Within 2 h of collection blood samples were centrifuged, and then the EDTA plasma was separated and stored at Ϫ20°C. Total plasma homocysteine was determined by HPLC with fluorescence detection as previously described by Ubbink et al. 22 Before reversed-phase HPLC analysis, the plasma thiols were derived with ammonium 7-fluorobenzo-2-oxa-],3-diazole-4sulphonate, a thiol-specific fluorogenic probe that is commercially available. The method is simple, sensitive, reproducible (between-run coefficient of variation of 6.6%), and very suitable for routine determination of tHcy levels. Urinary albumin excretion (UAE) was measured by nephelometry (Microalbuminuria Kit, Kone Diagnostics, Espoo, Finland), and microalbuminuria was defined as urinary albumin excretion greater than or equaling 30 mg/24 h and less than 300 mg/24 h. All the other parameters were analyzed as described in previous studies. 4, 21, 23 A positive smoking history was recorded when the individual was still a smoker, or had quit less than 1 year before being interviewed. Atherothrombotic and cardiovascular complications were established on the basis of recorded documentation of myocardial infarction, stroke, coronary artery disease, cerebrovascular or peripheral vascular disease, retinopathy, nephropathy, and using standardized enzymatic/ECG, computed tomography scan, angiography, or B-mode/Doppler ultrasound.
Descriptive values were expressed as mean Ϯ SD. Differences between groups, due to a not normal data distribution, were tested with Kolmogorov-Smirnov two-samples test. Spearman's rank correlation coeffi-cient was used to assess the correlations between variables. Values of mean arterial pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (DBP), urinary albumin excretion, homocysteine, folate, and vitamin B 12 were natural logarithm transformed, as required, to improve normality.
Linear regression analysis and multiple stepwise regression models were executed. Kruskal-Wallis analysis of variance was used, to assess differences between percentiles' groups. Fisher's exact test was used to evaluate propensity towards hyperhomocysteinemia in microalbuminurics versus normoalbuminurics.
Statistical analyses were performed using the software Statgraphics. A value of P Յ .05 was considered significant.
RESULTS

Characteristics of the Patient Populations
The characteristics of the NIDDM group are summarized in Table 1 . The patients appeared fairly well compensated, and 17 of them presented complications (retinopathy, n ϭ 5; coronary artery disease, n ϭ 4; stroke, n ϭ 3; previous myocardial infarction, n ϭ 2; and thromboembolism, n ϭ 1).
All of them were treated with diet or hypoglycemic agents alone. Nine of the patients were smokers. No associations were demonstrated between smoking and each metabolic parameter considered. A significant difference was observed as regards body mass index (BMI) between patients and controls (23.2 Ϯ 2.6 v 27.4 Ϯ 4.3; P Ͻ .05). Plasma tHcy levels under fasting conditions (8.121 Ϯ 3.179 v 7.199 Ϯ 2.409 mol/L, Kolmogorov-Smirnov value [KS] ϭ 0.319; P ϭ .99) and after a methionine load were similar in the NIDDM versus the control subjects ( Table 1) . As regards urinary albumin excretion, 17 of 33 NIDDM patients (51.5%) had values greater than 30 mg/24 h, and were considered microalbuminurics, 16 were normoalbuminurics, and none had overt proteinuria. Furthermore, patients with atherothrombotic complications had higher tHcy values (9.61 Ϯ 3.34 v 6.53 Ϯ 2.09 mol/L; P ϭ .003).
Correlations and Multivariate Analysis
The correlations between arterial blood pressure and all the other parameters were analyzed, and, due to the presence of a not-normal distribution, Spearman's rank coefficient was evaluated. There were negative correlations between folate and mean arterial pressure (r ϭ Ϫ0.352, P ϭ .046) ( Figure 1) ; folate and systolic blood pressure (r ϭ Ϫ0.436, P ϭ .013) ( Figure 1) ; and tHcy and vitamin B 12 (r ϭ Ϫ0.348, P ϭ .04). In addition, positive correlations appeared between vitamin B 12 and folate (r ϭ 0.499, P ϭ .004), glycosylated hemoglobin and glucose blood levels (r ϭ 0.374, P ϭ .03), and fasting and postload tHcy and urinary albumin excretion. After a logarithmic transformation, the correlations between the parameters were reanalyzed by linear regression analysis, and an inverse correlation between ln tHcy and ln folate was revealed. Otherwise, a slight correlation (even if not significant) appeared between ln tHcy and ln MAP (r ϭ 0.25), and between ln tHcy and ln DBP (r ϭ 0.27). By using multiple regression analysis, all the arterial blood pressure parameters were tested for tHcy, UAE, folate, vitamin B 12 , glucose blood levels, cholesterol, and glycosylated hemoglobin. The parameter that appeared to exert an independent effect on arterial blood pressure was folate for MAP (F ϭ 3.24, P ϭ .07).
Percentile Analysis A first percentile analysis was made by splitting the NIDDM patients into two groups, depending on whether their levels of each parameters were above the 75th percentile.
Patients with homocysteine levels higher than 9.4 mol/L had enhanced values of diastolic blood pres- Among the parameters considered, folate appeared to be related to arterial blood pressure. Systolic blood pressure (142.60 Ϯ 13.13 v 126.87 Ϯ 5.93 mm Hg; P ϭ .001), DBP, and mean arterial pressure were lower in the NIDDM patients who presented with higher folate values.
Low vitamin B 12 levels were associated with higher systolic (139.58 Ϯ 13.74 v 134.37 Ϯ 12.37 mm Hg; P ϭ .03) and diastolic blood pressure (Table 2) . No significant differences were associated with glycosylated hemoglobin.
Variance Analysis Using the Kruskal-Wallis test, patients were examined to see whether parameters were above or below the 75th percentile of their own distribution curve. This analysis allowed us to closely evaluate any differences between the groups by considering intra-and intergroup variations. Homocysteine, folate, and urinary albumin excretion appeared to be strongly related to arterial blood pressure among the parameters considered. The role of vitamin B 12 was slightly reduced if the groups were analyzed using this method. As regards the predictive values of ln diastolic blood pressure both for ln tHcy and ln folate using regression analysis, we obtained a remarkable effect, ie, an increase in tHcy levels from 6 to 12 mol/L, associated with a rise in DBP values of 4.5 mm Hg. If tHcy levels increased threefold (from 6 to 18 mol/L), we observed an increase of 8 mm Hg in DBP values. Moreover, if plasma folate values increased from 40 to 80 ng/mL, a decrease of 4 mm Hg in DBP values was observed. 
Analysis of Microalbuminuria
DISCUSSION
The concentration of homocysteine in the plasma is regulated by several factors, genetic and acquired. [1] [2] [3] [4] Elevated concentrations of homocysteine, both under fasting conditions and postmethionine load conditions, were correlated with several atherothrombotic and cardiovascular disorders. [23] [24] [25] [26] [27] [28] [29] Previous studies have discussed the potential interaction between tHcy and glucose intolerance as a risk factor for atherosclerosis. 30 -33 Also, as suggested in previous studies, no difference were observed between our diabetic patients and controls as regards plasma tHcy levels, folate, and vitamin B 12 values. When the subjects were grouped in deciles of plasma vitamin concentration, the mean plasma tHcy levels were higher in the lowest deciles of vitamin B 12 and folic acid concentrations, but it has been well established that folate and vitamin deficiencies may result in hyperhomocysteinemia. Otherwise, previous studies have suggested that plasma folate and vitamin B 12 concentrations are related to an increased risk of coronary artery disease, but this risk disappeared after adjustment for plasma tHcy concentrations. 14 In our study a correlation between several parameters involved in the methionine-homocysteine pathways (such as plasma folate and tHcy levels) and AJH -SEPTEMBER 1998 -VOL. 11, NO. 9 hemodynamic data was shown. Correlations were observed between folate and both MAP and SBP, respectively, whereas this was not confirmed with vitamin B 12 . As regards the relationship between parameters and arterial blood pressure, it is important to distinguish between results that are identical and those that are not statistically significantly different. For example, MAP values in the groups above or below the 75th percentile of vitamin B 12 distribution are not statistically significant, despite a 5-mm Hg difference in mean arterial pressure. In a metaanalysis involving 420,000 patients, a 5-mm Hg difference in diastolic pressure was associated with 34% fewer strokes and 21% less coronary heart disease. 34 After a multiplestepwise regression analysis, only folate appeared to be independently linked to MAP, even if only slightly. This means that it is difficult to speculate whether folate and vitamin B 12 could be related to arterial regulatory tone only through the tHcy pathway.
It is likely that the control of vitamin B 12 and folate in NIDDM patients, either by increased dietary intake or vitamin supplement, can prevent an increase in tHcy levels. The correct treatment of an elevated plasma tHcy concentration by harmless vitamin supplements constitutes no health risk but may generate benefits in slowing atherothrombotic events, expecially in microalbuminuric NIDDM patients. The Kruskal-Wallis analysis of percentile variance allowed us to observe how higher tHcy values were correlated with increased diastolic blood pressure and mean arterial pressure values, but not with systolic blood pressure values. A twofold increase in tHcy values (from 6 to 12 mol/L) on a logarithmic scale was associated with 4.5-mm Hg increase in DBP values (this means three more strokes and two more coronary events per 10 patients). If a threefold increase was considered, on the regression analysis of predictive values, an increase of 8 mm Hg was observed. These plasma tHcy values were not so rare in a randomized cohort of patients.
Several potential mechanisms could be proposed for the relationship between folate, tHcy, vitamin B 12 , and microalbuminuria with blood pressure parameters, in NIDMM patients. These patients presented a decreased synthesis and an increased inactivation of endothelial nitric oxide by oxygen-derived free radicals or advanced glycosylated end products. 35 NIDDM patients, particularly those with microalbuminuria, could represent a group of patients with a major propensity toward endothelial dysfunction, which could be revealed by slight alterations in plasma tHcy, folate, or vitamin B 12 levels.
Recently a correlation between systolic blood pressure and plasma tHcy was demonstrated in a hypertensive geriatric population. 36 It is possible that in conditions of reduced NO production, such as in NIDDM patients, a slight increase in tHcy (due to a decrease in folate or vitamin B 12 levels) could scavenge residual endothelial nitric oxide and influence arterial regulatory tone. Homocysteine enhancement could be the link between high blood pressure, increased urinary albumin excretion, and elevated atherothrombotic events, which we observed in welltreated and compensated NIDDM patients (Figure 3 ).
